i
Six-Month Response to Delamanid Treatment in MDR TB Patients
-
Oct 17 2017
Source: Emerg Infect Dis. 23(10):1746-1748.
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing treatment for MDR TB. Results show good tolerability and treatment response at 6 months.
-
Subjects:
-
Pubmed ID:28767036
-
Pubmed Central ID:PMC5621551
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: